From: Metabolic phenotypes in primary unknown metastatic carcinoma
Parameters | Glycolysis type | Glutaminolysis type | Mitochondrial type | ||||||
---|---|---|---|---|---|---|---|---|---|
Yes | No | p-value | Yes | No | p-value | Yes | No | p-value | |
n = 2 (%) | n = 75 (%) |  | n = 8 (%) | n = 69 (%) |  | n = 74 (%) | n = 3 (%) | ||
Age | Â | Â | 0.547 | Â | Â | 0.710 | Â | Â | 0.741 |
 <50 | 1 (50.0) | 24 (32.0) |  | 3 (37.5) | 22 (31.9) |  | 3 (25.0) | 22 (33.8) |  |
 ≥50 | 1 (50.0) | 51 (68.0) |  | 5 (62.5) | 47 (68.1) |  | 9 (75.0) | 43 (66.2) |  |
Sex | Â | Â | 0.524 | Â | Â | 0.466 | Â | Â | 0.351 |
 Male | 2 (100.0) | 46 (61.3) |  | 4 (50.0) | 44 (63.8) |  | 6 (50.0) | 42 (64.6) |  |
 Female | 0 (0.0) | 29 (38.7) |  | 4 (50.0) | 25 (36.2) |  | 6 (50.0) | 23 (35.4) |  |
Clinical subtype | Â | Â | 0.627 | Â | Â | 0.857 | Â | Â | 0.533 |
 Nodal type | 1 (50.0) | 33 (44.0) |  | 3 (37.5) | 31 (44.9) |  | 5 (41.7) | 29 (44.6) |  |
 Single organ type | 1 (50.0) | 14 (18.7) |  | 1 (12.5) | 14 (20.3) |  | 4 (33.3) | 11 (16.7) |  |
 Intermediate type | 0 (0.0) | 14 (18.7) |  | 2 (25.0) | 12 (17.4) |  | 1 (8.3) | 13 (20.0) |  |
 Carcinomatosis type | 0 (0.0) | 14 (18.7) |  | 2 (25.0) | 12 (17.4) |  | 2 (16.7) | 12 (18.5) |  |
Histologic type | Â | Â | 0.050 | Â | Â | 0.237 | Â | Â | 0.049 |
 AD | 0 (0.0) | 27 (36.0) |  | 5 (62.5) | 22 (31.9) |  | 8 (66.7) | 19 (29.2) |  |
 PD | 2 (100.0) | 14 (18.7) |  | 2 (25.0) | 14 (20.3) |  | 2 (16.7) | 14 (21.5) |  |
 SQ | 0 (0.0) | 20 (26.7) |  | 1 (12.5) | 19 (27.5) |  | 0 (0.0) | 20 (30.8) |  |
 UP | 0 (0.0) | 14 (18.7) |  | 0 (0.0) | 14 (20.3) |  | 2 (16.7) | 12 (18.5) |  |
Organs involved | Â | Â | 0.439 | Â | Â | 0.003 | Â | Â | 0.121 |
 Lymph node | 1 (50.0) | 48 (64.0) |  | 4 (50.0) | 45 (65.2) |  | 6 (50.0) | 43 (66.2) |  |
 Bone | 1 (50.0) | 9 (12.0) |  | 0 (0.0) | 10 (14.5) |  | 3 (25.0) | 7 (10.8) |  |
 Brain | 0 (0.0) | 9 (12.0) |  | 0 (0.0) | 9 (13.0) |  | 0 (0.0) | 9 (13.8) |  |
 Other | 0 (0.0) | 9 (12.0) |  | 4 (50.0) | 5 (7.2) |  | 3 (25.0) | 6 (9.2) |  |